Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge.
Oncology Department, Saint Joseph University, Beirut, Lebanon.|Oncology Department, Jules Bordet Institute, Brussels, Belgium.
Hampig Raphael
HR
Kourie
Oncology Department, Saint Joseph University, Beirut, Lebanon.|Hematology-Oncology Department, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Samer
S
Tabchi
Oncology Department, Saint Joseph University, Beirut, Lebanon.
Joseph
J
Kattan
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D058990:Molecular Targeted Therapy / Q000379:methods*
D000970:Antineoplastic Agents
Hodgkin's lymphoma; brentuximab vedotin; challenge; checkpoint inhibitors; chemotherapy; ethics; ipilimumab; nivolumab; targeted therapies; trials